HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Surface markers of peripheral blood lymphocytes in Vogt-Koyanagi-Harada disease.

Abstract
The cell membrane markers on peripheral blood lymphocytes of 10 patients with Vogt-Koyanagi-Harada disease (VKH) were analyzed by laser flow cytometry using monoclonal antibodies. Seven patients with active uveitis and 98 normal control subjects were also studied. The percentage of OKT3+, OKT4+ and OKT11+ cells were significantly lower while OKIa1+ cell were higher in VKH compared to controls. The percentage of cells reacting with monoclonal antibodies were slightly affected during steroid therapy, but returned to the pretreatment level after cessation of the therapy. OKIa1+ cells were shown to be increased in active uveitis while percentages of cells with other cell markers remained unchanged when the results were compared with that of the control. The findings suggest that the analysis of cell membrane markers on lymphocytes in VKH could be a significant parameter in clinical medicine.
AuthorsK Okubo, S Kurimoto, K Okubo, K Matsumoto, M M Yokoyama
JournalJournal of clinical & laboratory immunology (J Clin Lab Immunol) Vol. 17 Issue 1 Pg. 49-52 (May 1985) ISSN: 0141-2760 [Print] Scotland
PMID3840207 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
Topics
  • Adult
  • Aged
  • Antibodies, Monoclonal (immunology)
  • Cell Membrane (immunology)
  • Female
  • Humans
  • Immunity, Cellular
  • Lymphocytes (classification, immunology)
  • Male
  • Middle Aged
  • Uveitis (immunology)
  • Uveomeningoencephalitic Syndrome (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: